Competition has heated up for the promoter stake in Cipla, one of India’s largest pharmaceutical companies. Global private equity firms, including Blackstone, and Indian companies like Torrent Pharma have expressed interest in acquiring the stake. The promoter stake alone is valued at approximately $3.80 billion. The merged entity between Dr. Reddy’s and Cipla would become the second-largest Indian-origin pharmaceutical company in terms of domestic revenue. Overall, the competition for the promoter stake in Cipla reflects the attractiveness of the company and its potential for growth and expansion in the pharmaceutical industry.

Source: Economic Times September 05, 2023 17:50 UTC